Advanced mesenchymal stem cell therapy and exosome therapy for multiple sclerosis in Istanbul, designed for patients seeking investigational regenerative support for autoimmune demyelination, neuroinflammation, and neurological function.
Wharton's Jelly MSCs · IV + Intrathecal + Intranasal · RRMS, SPMS & PPMS evaluation · MRI & EDSS-based review
How treatment is delivered
For neurological conditions the route matters as much as the product. Your physician may combine intrathecal, intravenous and intranasal delivery in a single program, chosen after reviewing your history, imaging and goals.
A physician places the preparation into the cerebrospinal fluid through a fine needle at the lower back, under sterile conditions. That fluid surrounds the spinal cord and the brain, which is why this route is central to these programs.
Stem cells and exosomes are given as a calm, monitored infusion. The circulation carries them through the body, where they are studied for their signalling and immune-modulating effects.
Exosomes are also given as a nasal spray. The route is studied because the olfactory nerve offers a short pathway toward the brain, and it needs no needle at all.
Your care, the science, your goals
Follow a visual journey from your assessment to the biological ideas being explored. These silent, illustrative films help you prepare for a personal conversation about care in Istanbul.
01 Your assessment
A conversation about multiple sclerosis begins with your health history, current care and what you hope to improve. Our Istanbul team can help you explore the next step in an individual medical review.
The scene introduces the subject of your assessment. Your own examination, investigations and care plan will be individual to you.
02 Inside the concept
The nervous system depends on communication between nerve cells and their surrounding support cells. Researchers investigate this environment, including inflammation and cellular signals. These ideas are distinct from evidence that a treatment restores neurological function.
03 Your goals
Talk to us about the activities, comfort and wellbeing that matter most to you. A useful consultation connects those personal goals with realistic options, the available evidence and a clear plan for follow-up.
Discuss possible benefits, risks, alternatives and the possibility of no improvement before deciding.
Your questions deserve a personal answer.
Living with multiple sclerosis?
Submit your MRI scans, EDSS score, relapse history, and current medication plan for a free evaluation.
Multiple sclerosis (MS) is a chronic autoimmune neurological disease in which the immune system attacks myelin, the protective covering surrounding nerve fibers in the central nervous system. When myelin becomes inflamed or damaged, nerve signaling slows down or becomes disrupted, producing symptoms that can range from mild sensory disturbance to severe mobility impairment.
MS may present as relapsing-remitting MS (RRMS), secondary progressive MS (SPMS), or primary progressive MS (PPMS). Disease-modifying therapies remain central to conventional management, but they do not fully reverse established neurological injury. This is why many patients begin exploring mesenchymal stem cell therapy and exosome therapy as complementary regenerative strategies.
MS is not just a problem of damaged nerves. It is an immune-driven inflammatory process involving autoreactive T cells, B cells, cytokines, microglial activation, blood-brain barrier disruption, and progressive stress on axons and oligodendrocytes. In many patients, the immune system remains the main engine driving injury, even as disability gradually accumulates.
That is why interest in stem cell therapy for multiple sclerosis continues to grow. Patients are not only looking for symptomatic support. They are looking for strategies that may help regulate immune behavior, reduce neuroinflammatory activity, support a healthier CNS environment, and potentially improve neurological stability alongside formal neurological care.
Patients searching for MS stem cell therapy in Turkey often struggle with a combination of inflammatory, neurological, and functional issues:
Many MS patients experience flare-like inflammatory episodes that can create new neurological symptoms or worsen existing deficits.
Weakness, spasticity, gait instability, and coordination problems can interfere with walking, endurance, and independence.
MS-related fatigue can be severe and disproportionate, often paired with reduced mental clarity, slower processing, and cognitive strain.
Bladder urgency, numbness, neuropathic discomfort, balance issues, and visual symptoms can all reduce quality of life.
Wharton's Jelly mesenchymal stem cells (WJ-MSCs) are studied in MS because they may influence multiple disease-relevant pathways at the same time. Rather than acting like a narrow single-target medication, they are explored for broad immunomodulatory and neuro-supportive effects.
Because MS is immune-mediated, one of the biggest reasons patients explore MSC therapy is its potential role in modulating autoreactive immune behavior. This includes interest in reducing inflammatory cascades, improving immune tolerance signaling, and supporting a less aggressive CNS inflammatory environment.
Chronic CNS inflammation can worsen demyelination and create a hostile environment for neuronal tissue. MSC-based therapy is explored for anti-inflammatory signaling that may help calm this environment and reduce the intensity of inflammatory damage.
MS patients are often interested in strategies that may support oligodendrocyte pathways, myelin-preservation mechanisms, and broader neuroprotective signaling. This is particularly relevant in patients concerned about progression, lesion accumulation, and long-term functional decline.
Exosome therapy is often discussed as an adjunctive part of regenerative MS protocols. Exosomes are nano-sized extracellular vesicles that may carry anti-inflammatory microRNAs, growth factors, and signaling proteins that interact with the neurological immune environment.
In MS, exosome therapy is explored because these vesicles may support CNS-targeted anti-inflammatory communication, microglial regulation, and neurotrophic signaling. Intranasal delivery is especially attractive for some patients because it offers a non-invasive route aimed at central nervous system access.
Submit your brain and spine MRI, EDSS score, relapse history, current disease-modifying treatment, and neurologist reports for a personalized case review.
Not every patient is searching for the same outcome. Some are focused on inflammatory stabilization. Others are more concerned about progressive decline, fatigue, mobility, or quality of life. Common motivations include:
Stem cell therapy is studied because MS is fundamentally an immune-mediated disease, not just a structural one.
Ongoing CNS inflammation is a major target in regenerative MS protocols, especially when disease activity remains clinically important.
Patients often explore treatment in hopes of supporting a healthier environment for myelin preservation and neurological stability.
Many patients are seeking support for fatigue, mobility, balance, cognition, bladder symptoms, and progression-related decline.
Eligibility for multiple sclerosis treatment in Istanbul depends on the full neurological picture, not just the diagnosis label:
As a guide, most candidates have an EDSS score between 1.5 and 7.5, are fit to travel, and can tolerate IV infusion and, where consented, intrathecal injection. Final candidacy depends on MRI findings, relapse pattern, MS subtype, disability level, infection risk, medication status, and overall safety assessment.
Active malignancy, severe infection, pregnancy, and recent use of certain disease-modifying therapies (for example alemtuzumab within 12 months) require individual medical assessment. We coordinate DMT timing with your neurologist.
Submit brain and spine MRI scans, EDSS score if available, relapse history, symptom profile, and current disease-modifying therapies for candidacy review.
If appropriate, a tailored treatment outline is prepared based on disease pattern, route selection, timing, and realistic expectations.
Protocols may include IV stem cell therapy, intrathecal administration, and selected exosome support depending on the case.
Follow-up may include neurological reassessment, symptom tracking, MRI comparison over time, and review of progression-related outcomes.
| Day | What happens |
|---|---|
| Day 1 | Arrival in Istanbul, airport pickup, hotel check-in and evening medical intake. |
| Day 2 | Neurological assessment, labs, EDSS scoring, MRI review and final treatment plan. |
| Day 3 | First IV infusion of GMP-expanded Wharton's jelly MSCs (typically 100–200 million cells). |
| Day 4 | Intrathecal MSC injection under image guidance, where indicated and consented. |
| Day 5 | Second IV infusion, MSC-derived exosome adjunct, observation and departure briefing. |
Programs fall within our neurological range of €9,000 – €25,000. See the stem cell therapy cost guide for what every quote includes.
Patients seeking MS stem cell therapy in Turkey usually want a combination of neurological case review, regenerative medicine access, international travel support, and a better private treatment cost structure.
Istanbul offers strong private healthcare access for international patients seeking regenerative and neuroimmunology-oriented treatment options.
Our programs combine MSC-based immune modulation with exosome-based neuroinflammatory support in a structured treatment pathway.
MS patients need individualized screening based on MRI activity, relapse history, EDSS level, DMT status, and disease subtype.
Turkey often offers a major cost advantage versus comparable private regenerative medicine programs in the US and UK.
Stem cell therapy for multiple sclerosis is investigational. Results vary significantly. Treatment does not replace neurologist care, MRI monitoring, or disease-modifying therapies when medically indicated.
Explore related regenerative medicine approaches and learn more about our clinic, research standards, and patient support.
Submit your MRI scans and neurological records for a free evaluation. Istanbul offers a major cost advantage compared with many US or UK private clinics.
Or call directly: +90 534 856 92 92
Optional analytics is off until you choose.
May we use Google Analytics cookies to count interactions such as consultation requests and contact-button clicks? Your choice is optional and does not affect access to our services. You can change it here at any time. Read our privacy policy.
